106 related articles for article (PubMed ID: 32812284)
1. Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis.
Pecoraro A; Knipper S; Palumbo C; Rosiello G; Luzzago S; Tian Z; Shariat SF; Saad F; Briganti A; Fiori C; Porpiglia F; Karakiewicz PI
J Surg Oncol; 2020 Dec; 122(7):1506-1513. PubMed ID: 32812284
[TBL] [Abstract][Full Text] [Related]
2. A non-cancer-related survival benefit is associated with partial nephrectomy.
Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Partial Versus Radical Nephrectomy Effect on Other-cause Mortality, Cancer-specific Mortality, and 30-day Mortality in Patients Older Than 75 Years.
Marchioni M; Preisser F; Bandini M; Nazzani S; Tian Z; Kapoor A; Cindolo L; Abdollah F; Tilki D; Briganti A; Montorsi F; Shariat SF; Schips L; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):467-473. PubMed ID: 29398456
[TBL] [Abstract][Full Text] [Related]
4. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
5. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
[TBL] [Abstract][Full Text] [Related]
6. A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer.
Knipper S; Pecoraro A; Palumbo C; Rosiello G; Luzzago S; Tian Z; Briganti A; Saad F; Tilki D; Graefen M; Karakiewicz PI
Clin Genitourin Cancer; 2019 Oct; 17(5):395-401. PubMed ID: 31416752
[TBL] [Abstract][Full Text] [Related]
7. Rates of other-cause mortality after radical cystectomy are decreasing over time-A population-based analysis over two decades.
Rosiello G; Knipper S; Palumbo C; Pecoraro A; Luzzago S; Deuker M; Stolzenbach LF; Tian Z; Gallina A; Gandaglia G; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
J Surg Oncol; 2020 Jun; 121(8):1329-1336. PubMed ID: 32246846
[TBL] [Abstract][Full Text] [Related]
8. Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma.
Mazzone E; Nazzani S; Preisser F; Tian Z; Marchioni M; Bandini M; Capitanio U; Kapoor A; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; I Karakiewicz P
Cancer Epidemiol; 2018 Oct; 56():118-125. PubMed ID: 30173050
[TBL] [Abstract][Full Text] [Related]
9. Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities.
Sun M; Bianchi M; Trinh QD; Hansen J; Abdollah F; Hanna N; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
BJU Int; 2013 Jan; 111(1):67-73. PubMed ID: 22612472
[TBL] [Abstract][Full Text] [Related]
10. Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy.
Cano Garcia C; Flammia RS; Piccinelli M; Panunzio A; Tappero S; Barletta F; Incesu RB; Law KW; Morra S; Tian Z; Saad F; Kapoor A; Shariat SF; Longo N; Tilki D; Briganti A; Terrone C; Antonelli A; De Cobelli O; Hoeh B; Kluth LA; Chun FKH; Karakiewicz PI
Clin Genitourin Cancer; 2024 Feb; 22(1):1-6. PubMed ID: 37344282
[TBL] [Abstract][Full Text] [Related]
11. Partial and radical nephrectomy provide comparable long-term cancer control for T1b renal cell carcinoma.
Meskawi M; Becker A; Bianchi M; Trinh QD; Roghmann F; Tian Z; Graefen M; Perrotte P; Karakiewicz PI; Sun M
Int J Urol; 2014 Feb; 21(2):122-8. PubMed ID: 23819700
[TBL] [Abstract][Full Text] [Related]
12. Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma.
Trudeau V; Larcher A; Sun M; Boehm K; Dell'Oglio P; Sosa J; Tian Z; Fossati N; Briganti A; Shariat SF; Karakiewicz PI
World J Urol; 2016 Oct; 34(10):1429-36. PubMed ID: 26902877
[TBL] [Abstract][Full Text] [Related]
13. Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer.
Pecoraro A; Palumbo C; Knipper S; Mistretta FA; Tian Z; Shariat SF; Saad F; Briganti A; Fiori C; Porpiglia F; Karakiewicz PI
J Urol; 2019 Dec; 202(6):1120-1126. PubMed ID: 31347950
[TBL] [Abstract][Full Text] [Related]
14. Assessment of survival of patients with metastatic clear cell renal cell carcinoma after radical cytoreductive nephrectomy versus no surgery: a seer analysis.
Xiao WJ; Zhu Y; Dai B; Zhang HL; Ye DW
Int Braz J Urol; 2015; 41(2):288-95. PubMed ID: 26005970
[TBL] [Abstract][Full Text] [Related]
15. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
Daugherty M; Bratslavsky G
Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
[TBL] [Abstract][Full Text] [Related]
16. Results of a comparative study analyzing octogenarians with renal cell carcinoma in a competing risk analysis with patients in the seventh decade of life.
May M; Cindolo L; Zigeuner R; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Wolff I; Feciche B; Fenske F; Pichler M; Schips L; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Waidelich R; Stief C; Sountoulides P; Brookman-May S; ;
Urol Oncol; 2014 Nov; 32(8):1252-8. PubMed ID: 25129141
[TBL] [Abstract][Full Text] [Related]
17. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management.
Sun M; Becker A; Tian Z; Roghmann F; Abdollah F; Larouche A; Karakiewicz PI; Trinh QD
Eur Urol; 2014 Jan; 65(1):235-41. PubMed ID: 23567066
[TBL] [Abstract][Full Text] [Related]
18. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
[TBL] [Abstract][Full Text] [Related]
19. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
[TBL] [Abstract][Full Text] [Related]
20. Impact of Perioperative Infection on Cancer Specific Survival after Nephrectomy for Renal Cell Carcinoma.
Tallman JE; Pearce SM; Kuchta K; Helfand BT; Eggener SE
J Urol; 2017 Nov; 198(5):1027-1032. PubMed ID: 28551443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
